Core Viewpoint - The financial system is becoming a key support for energy resource security, with China Galaxy Securities innovating financial tools and optimizing capital allocation to enhance financial services for energy and resource sectors [1] Group 1: Energy Security and Financial Support - China Galaxy Securities has established a comprehensive financial service system covering the entire energy and resource industry chain, supporting energy supply and resource security [1] - The company played a crucial role in the restructuring project of Huadian International, which is the largest restructuring project in the thermal power industry for 2025, involving over 16 million kilowatts of operational capacity [2] - The restructuring project aims to stabilize the power grid by enhancing the peak-shaving capabilities of thermal power, thus ensuring national electricity security [2] Group 2: Financing and Investment Activities - In 2025, China Galaxy Securities assisted multiple energy companies in direct financing to strengthen national energy security, including helping Jiadeng Co. complete over 1.1 billion yuan in refinancing [3] - The company also supported State Grid New Energy in completing a 36.5 billion yuan capital increase project, which is significant for the pumped storage sector [3] - China Galaxy Securities customized financing solutions for these projects, achieving record cash fundraising in state asset transactions [3] Group 3: Resource Development and International Cooperation - China Galaxy Securities acted as the lead underwriter for Jinchengxin's convertible bond issuance, raising 2 billion yuan to enhance copper mining efficiency in Zambia [4] - The project aligns with China's status as the largest refined copper producer and consumer, aiming to deepen economic and resource cooperation with Belt and Road Initiative countries [4] - The company also supported the listing of leading tungsten mining company Jiaxin International in Hong Kong and facilitated the issuance of a pioneering bond for Xibu Mining [5] Group 4: Global Expansion and Market Integration - As Chinese energy companies expand internationally, China Galaxy Securities has been instrumental in facilitating overseas financing, including a significant share placement for Ruipu Lanjun in Hong Kong [6] - The company successfully led the underwriting of a panda bond for Shandong-based Water Development Energy, marking a significant entry into the interbank bond market [6] - Overall, China Galaxy Securities has developed a comprehensive service capability across private equity, A-shares, H-shares, and bond markets, demonstrating its role in supporting the national energy resource security system [6]

纯债规模承压，杠杆久期策略分化 ——Q4 债券基金季报分析 核心观点 基金规模：债基规模回升，其中纯债基收缩。 2025 年债基规模扩张但纯债基收缩。配置上，利率债减、信用债增。全 年来看，截至 Q4，全市场公募基金总规模为 36.38 万亿元，其中债基规 模扩张 0.64 万亿元，但纯债基规模收窄 0.8 万亿元。四季度来看，在基金 规模具体变动方面，2025Q4 仅混合型基金规模较 Q3 收缩，规模回落 0.14 万亿元至 3.62 万亿元、其余类型基金均规模回升，尤其债券型基金和货 币市场型基金规模扩张幅度最大，分别增加 0.47 万亿元、0.34 万亿元至 11.03 万亿元、15.01 万亿元。在基金发行与到期方面，Q4 纯债基金（封 闭型+开放型）新发数量 11 只，发行规模为 85.45 亿元；到期数量 28 只， 到期规模为 204.98 亿元；目前来看 2026Q1 可能到期纯债基金约有 3 只， 规模在 2.82 亿元左右。券种配置方面， Q4 纯债基金的债券持仓市值占 基金总值比为 96.87%，（高于基金整体债券占比的 53.44%），相较 Q3 环比增加 0.12 个百分点，近年来整 ...

Core Viewpoint - China Galaxy Securities is optimistic about the pharmaceutical industry's investment opportunities in 2026, focusing on hard technology in medicine, innovation, and overseas expansion, while seeking alpha in niche segments [1] Group 1: Investment Trends - In Q4 2025, public fund holdings in pharmaceuticals decreased, indicating an overall low allocation level [1] - The market value of pharmaceutical theme funds decreased by 9.73% to 205.9 billion yuan, which is 66.54% higher than the average since 2019 [1] - The market value of the pharmaceutical biotechnology sector fell by 18.81% to 312.5 billion yuan, with a holding ratio of 8.12%, below the historical average by 3.89 percentage points [1] Group 2: Stock Performance - The top five pharmaceutical stocks held by public funds in Q4 2025 saw significant reductions in both the number of funds and total market value, with notable declines in stocks like Heng Rui Medicine and WuXi AppTec [2] - The concentration of holdings has shifted from innovative drugs to medical devices and services, indicating a change in market investment focus [2] Group 3: Industry Data Overview - The pharmaceutical manufacturing industry's revenue has shown a slight decline, with a year-on-year decrease of 1.2% in Q4 2025 [3] - Medical service volumes remained stable, with a total of 1.86 billion outpatient visits in early 2025, reflecting a 0.1% year-on-year decrease [3] - The overall operation of the medical insurance fund has been stable, with total income of 2.632 trillion yuan and total expenditure of 2.110 trillion yuan from January to November 2025 [3] Group 4: Market Comparison - The pharmaceutical industry has underperformed compared to the CSI 300 index, with a rolling P/E ratio of 38.19 compared to 14.14 for the CSI 300, indicating a premium of 170.14% over the index [3] - The SW pharmaceutical biotechnology index increased by 1.44% from early 2024 to January 28, 2026, while the CSI 300 rose by 37.15%, showing a relative underperformance of 35.71% for the pharmaceutical sector [3]

每经AI快讯，港股中资券商股普遍上扬，截至发稿，中国银河(06881.HK)涨4.49%，报10.94港元；光大 证券(06178.HK)涨3.4%，报9.13港元；招商证券(06099.HK)涨3.41%，报15.15港元；中信证券 (06030.HK)涨3.1%，报29.9港元。 ...

Core Viewpoint - Chinese brokerage stocks have generally risen, with several firms reporting positive earnings forecasts, indicating a strong performance outlook for the sector [1] Group 1: Stock Performance - As of the report, China Galaxy (601881) increased by 4.49% to HKD 10.94, Everbright Securities (601788) rose by 3.4% to HKD 9.13, China Merchants Securities (600999) gained 3.41% to HKD 15.15, and CITIC Securities (600030) went up by 3.1% to HKD 29.9 [1] Group 2: Earnings Forecast - Data shows that as of January 28, 21 brokerage firms that have disclosed earnings forecasts or preliminary reports expect a total net profit of CNY 107.58 billion, representing a year-on-year increase of nearly 60% [1] - Shenwan Hongyuan believes that the active trading environment and the recovery of investment banking and public asset management businesses confirm the high growth trend in brokerage earnings for 2025 [1] Group 3: Future Opportunities - By 2026, wealth management and international business are expected to provide opportunities for brokerages, while mergers and acquisitions will optimize competitive behavior and improve resource allocation efficiency [1] - Demand for derivative products is anticipated to unlock the leverage ceiling for brokerages [1]

消息面上，近日，多家上市券商业绩预喜。有数据显示，截至1月28日，已披露业绩预告或快报的21家 券商，预计净利润总额达1075.87亿元，同比增幅近六成。申万宏源认为，在交投活跃度提升和投行、 公募资管业务底部复苏背景下，券商25年业绩高增态势得到确认。2026年，财富管理、国际业务给券商 发挥功能性带来机遇，并购重组优化券商竞争行为&提高资源配置效率，衍生品等客需业务打开券商杠 杆天花板。 智通财经APP获悉，中资券商股普遍上扬，截至发稿，中国银河(06881)涨4.49%，报10.94港元；光大证 券(06178)涨3.4%，报9.13港元；招商证券(06099)涨3.41%，报15.15港元；中信证券(06030)涨3.1%，报 29.9港元。 ...

Group 1 - The core viewpoint of the articles indicates a mixed performance in the chemical industry, with the China Rare Earth Industry Index rising by 2.8% and the China Petrochemical Industry Index declining by 0.2% [1] - The Wind data shows that the E Fund Chemical Industry ETF (516570) has seen a net inflow of approximately 400 million yuan over the past nine trading days [1] - China Galaxy Securities reports a negative growth in capital expenditure for the chemical industry since 2024, suggesting a potential contraction in supply due to the "anti-involution" trend and accelerated elimination of outdated overseas capacity [1] Group 2 - The "14th Five-Year Plan" emphasizes the need to expand domestic demand, setting the tone for the next five years, which, combined with the onset of the US interest rate cut cycle, is expected to open up demand space for chemical products [1] - The supply-demand bottom is believed to be firmly established, with strong policy expectations acting as a catalyst, leading to a potential upward turning point for the chemical industry by 2026 [1] - The industry is anticipated to transition from valuation recovery to earnings growth, referred to as the "Davis Double Play" [1]

Group 1 - The core viewpoint is that the non-ferrous metal sector is experiencing a rebound, with significant trading volume and price increases observed in related ETFs [1][3] - The non-ferrous metal sector is expected to enter a super cycle driven by the convergence of the "AI leap" and "century change," with historical patterns indicating that commodity cycles can last 25-30 years, with upward trends lasting 8-10 years [3] - Major non-ferrous metal ETFs, such as the one from China Merchants (159690), have a high concentration in key commodities like copper (31%), gold (14%), and aluminum (12%), which together account for nearly 60% of the portfolio [3] Group 2 - Analysts predict that by 2026, the non-ferrous metal industry may experience a bull market driven by a combination of monetary, demand, and supply factors [3] - The non-ferrous metal sector is characterized by a "leverage effect," where rising metal prices lead to significant profit increases for mining companies, resulting in a "Davis double play" scenario where net asset value increases multiple times compared to the commodity price itself [3]

Group 1 - The core viewpoint is that the non-ferrous metal sector is experiencing a significant upward trend, driven by a combination of the "AI leap" and the "century change" narrative, suggesting a super cycle for non-ferrous metals [1] - The popular ETF, Huabao Non-ferrous ETF (159876), saw a peak increase of 4% before a quick decline, followed by a V-shaped recovery, currently up by 0.3% [1] - There has been a substantial inflow of funds into the Huabao Non-ferrous ETF, with over 1.1 million shares net subscribed recently, and a total net inflow exceeding 1.4 billion yuan over the last 20 trading days, bringing the fund's total size to 2.68 billion yuan [1] Group 2 - Historical data indicates that each commodity cycle lasts approximately 25-30 years, with upward trends lasting 8-10 years and downward trends lasting 15-20 years, suggesting a long-term bullish outlook for the non-ferrous metal sector [2] - Institutions generally agree that the non-ferrous metal sector is likely to continue its bullish trend, with expectations of a bull market driven by monetary, demand, and supply factors by 2026 [2] - The Huabao Non-ferrous ETF (159876) and its linked fund (017140) cover a wide range of metals including copper, aluminum, gold, rare earths, and lithium, allowing for better exposure to various market cycles [2]

该ETF跟踪MSCI中国东盟经济互联指数，并采用创新的"经济暴露因子"筛选机制，重点投资于在两地市场具有实质业务联动与收入贡献的优质上市公司。产品同时 支持港元、美元及人民币多柜台交易，为投资者提供便捷高效的资产配置工具，分享中国与东盟经济融合发展的长期红利。 首只中国—东盟经济互联ETF登陆港交所 1月28日，银河博时MSCI中国东盟经济互联指数ETF（下简称"银河博时东盟ETF"））举办上市仪式，宣告正式登陆港交所交易。 据悉，"银河博时东盟ETF"跟踪MSCI中国东盟经济互联指数，采用创新编制的"经济暴露因子"筛选机制，聚焦在两地市场具有实质业务联动与收入贡献的优质上市 公司——通过统计"港股通"上市公司在东盟各国的收入占比，及东盟上市公司在中国内地与香港的收入占比，选取排名前50%的优质标的构建投资组合。 产品兼具价值与成长属性，根据MSCI截至2025年末的数据，产品中代表"新质生产力"的可选消费、信息技术、通信的相关股票市值占比近35%、金融相关股票市值 占比近35%，融合了两大市场产业互补优势。在交易设计上，产品同时支持港元、美元、人民币三种货币柜台交易，为全球投资者提供低成本、高便捷度的资产配 ...